Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

BACKGROUND: The phase 3 multinational SCARLET study evaluated the efficacy and safety of a recombinant human soluble thrombomodulin (ART-123) for treatment of sepsis-associated coagulopathy (SAC), which correlates with increased mortality risk in patients with sepsis. Although no significant reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Bruno, Fiancette, Maud, Helms, Julie, Mercier, Emmanuelle, Lascarrou, Jean-Baptiste, Kayanoki, Toshihiko, Tanaka, Kosuke, Fineberg, David, Vincent, Jean-Louis, Wittebole, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012451/
https://www.ncbi.nlm.nih.gov/pubmed/33788052
http://dx.doi.org/10.1186/s13613-021-00842-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012451/
https://www.ncbi.nlm.nih.gov/pubmed/33788052
http://dx.doi.org/10.1186/s13613-021-00842-4

Ejemplares similares